Finance

Beta
Lists
QNRX:NASDAQ
Quoin Pharmaceuticals Ltd - ADR
$4.45
+5.95%
(+0.25) 1D
$4.29
-3.60% (-0.16)
After hours
Closed: Jun 26, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QNRX...
Open
$4.10
High
$4.47
Low
$4.00
Mkt. cap
8.94M
Avg. vol.
462.32K
Volume
203.60K
52-wk high
$41.80
52-wk low
$3.25
EPS
-$577.30
Beta
1.56
Shares outstanding
2.01M
No. of employees
5
Open
$4.10
High
$4.47
Low
$4.00
Mkt. cap
8.94M
Avg. vol.
462.32K
Volume
203.60K
52-wk high
$41.80
52-wk low
$3.25
EPS
-$577.30
Beta
1.56
Shares outstanding
2.01M
No. of employees
5
News stories
From sources across the web
About Quoin Pharmaceuticals Ltd - ADR
CEO-
Employees5
Founded1986
Headquarters-
SectorBiotechnology
Websitequoinpharma.com
Analyst ratings
Based on 4 analysts giving stock ratings to QNRX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for QNRX in the last 3 months.
Highest
Current $4.45
$35.00 (+686.52%)
Average
$23.25 (+422.47%)
Lowest
$12.00 (+169.66%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Buy
Reiterated
$16.00
+259.6%
06/24/2026
Ashok Kumar
ThinkEquity
Buy
Initiated
$12.00
+169.7%
06/15/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$35.00
+686.5%
05/08/2026
Dev Prasad
Lucid Capital
Buy
Initiated
$30.00
+574.2%
05/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.05M
2.28M
3.10M
3.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.74M
1.74M
1.42M
1.70M
Operating expense
3.79M
4.02M
4.52M
5.13M
Total operating expenses
3.79M
4.02M
4.52M
5.13M
Operating income
-3.79M
-4.02M
-4.52M
-5.13M
Other non operating income
-6.00K
9.49K
364.00
-13.30K
EBT including unusual items
-3.70M
-3.95M
-4.35M
-5.00M
EBT excluding unusual items
-3.70M
-3.95M
-4.35M
-5.00M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.70M
-3.95M
-4.35M
-5.00M
Net profit margin
-
-
-
-
Earnings per share
-6.27
-6.70
-
-1.77
Interest and investment income
103.24K
62.27K
171.70K
146.78K
Interest expense
-
-
-
-
Net interest expenses
103.24K
62.27K
171.70K
146.78K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.77M
-3.99M
-4.50M
-5.11M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of QNRX
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer